People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alumis Inc. | — | Biotechnology | Series D+ | $240.0M | $433.1M | 2024 |
| Principia Biopharma Inc. | — | Biotechnology | Series C | $77.4M | $2.0B | 2015 |
MARTIN BABLER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MARTIN BABLER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Srinivas Akkaraju | 2 | 10 |
| Alan Colowick | 2 | 7 |
| Peter Thompson | 1 | 16 |
| Simeon George | 1 | 8 |
| Richard Gaster | 1 | 7 |
| James Tananbaum | 1 | 6 |
| Daniel Becker | 1 | 5 |
| MICHAEL DYBBS | 1 | 5 |
| Nassim Usman | 1 | 4 |
| Lewis J. Shuster | 1 | 4 |
| James B. Tananbaum | 1 | 4 |
| June Lee | 1 | 3 |
| Alan B. Colowick | 1 | 3 |
| Michael Rome | 1 | 3 |
| Vikram Bajaj | 1 | 3 |
| Mark Bradley | 1 | 3 |
| Sapna Srivastava | 1 | 3 |
| Zhengbin Yao | 1 | 2 |
| Simeon J. George, M.D. | 1 | 2 |
| John R. Schroer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.